ID   NAGAB_MOUSE             Reviewed;         415 AA.
AC   Q9QWR8; O88620; Q8R437; Q8VDK2;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 2.
DT   07-APR-2021, entry version 141.
DE   RecName: Full=Alpha-N-acetylgalactosaminidase;
DE            EC=3.2.1.49;
DE   AltName: Full=Alpha-galactosidase B;
DE   Flags: Precursor;
GN   Name=Naga;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9787108; DOI=10.1006/mgme.1998.2750;
RA   Wang A.M., Ioannou Y.A., Zeidner K.M., Desnick R.J.;
RT   "Murine alpha-N-acetylgalactosaminidase: isolation and expression of a
RT   full-length cDNA and genomic organization: further evidence of an alpha-
RT   galactosidase gene family.";
RL   Mol. Genet. Metab. 65:165-173(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=129/Sv; TISSUE=Liver;
RX   PubMed=9602128; DOI=10.1016/s0378-1119(98)00103-6;
RA   Herrmann T., Schindler D., Tabe H., Onodera O., Igarashi S., Polack A.,
RA   Zehnpfennig D., Tsuji S.;
RT   "Molecular cloning, structural organization, sequence, chromosomal
RT   assignment, and expression of the mouse alpha-N-acetylgalactosaminidase
RT   gene.";
RL   Gene 211:205-214(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ILS, and ISS;
RX   PubMed=11471062; DOI=10.1007/s00335-001-1001-x;
RA   Ehringer M.A., Thompson J., Conroy O., Xu Y., Yang F., Canniff J.,
RA   Beeson M., Gordon L., Bennett B., Johnson T.E., Sikela J.M.;
RT   "High-throughput sequence identification of gene coding variants within
RT   alcohol-related QTLs.";
RL   Mamm. Genome 12:657-663(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Kidney, Liver, Lung, Pancreas, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Removes terminal alpha-N-acetylgalactosamine residues from
CC       glycolipids and glycopeptides. Required for the breakdown of
CC       glycolipids. {ECO:0000250|UniProtKB:P17050}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cleavage of non-reducing alpha-(1->3)-N-acetylgalactosamine
CC         residues from human blood group A and AB mucin glycoproteins,
CC         Forssman hapten and blood group A lacto series glycolipids.;
CC         EC=3.2.1.49;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside IV(3)-alpha-GalNAc,IV(2)-alpha-Fuc-
CC         nLc4Cer(d18:1(4E)) + H2O = a neolactoside IV(2)-alpha-Fuc-
CC         nLc4Cer(d18:1(4E)) + N-acetyl-alpha-D-galactosamine;
CC         Xref=Rhea:RHEA:48212, ChEBI:CHEBI:15377, ChEBI:CHEBI:28471,
CC         ChEBI:CHEBI:28691, ChEBI:CHEBI:40356;
CC         Evidence={ECO:0000250|UniProtKB:P17050};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48213;
CC         Evidence={ECO:0000250|UniProtKB:P17050};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside IV(3)-alpha-GalNAc,IV(2)-alpha-Fuc-
CC         nLc4Cer(d18:0) + H2O = a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:0)
CC         + N-acetyl-alpha-D-galactosamine; Xref=Rhea:RHEA:49304,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:40356, ChEBI:CHEBI:91118,
CC         ChEBI:CHEBI:91119; Evidence={ECO:0000250|UniProtKB:P17050};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49305;
CC         Evidence={ECO:0000250|UniProtKB:P17050};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=globoside IV3GalNAc-Gb4Cer + H2O = globoside Gb4Cer + N-
CC         acetyl-alpha-D-galactosamine; Xref=Rhea:RHEA:48412,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:40356, ChEBI:CHEBI:88167,
CC         ChEBI:CHEBI:90400; Evidence={ECO:0000250|UniProtKB:P17050};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48413;
CC         Evidence={ECO:0000250|UniProtKB:P17050};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P17050}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000250|UniProtKB:P17050}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 27 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL87527.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF079458; AAC28851.1; -; mRNA.
DR   EMBL; AJ223966; CAA11703.1; -; Genomic_DNA.
DR   EMBL; AY079439; AAL87527.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY079440; AAL87528.1; -; Genomic_DNA.
DR   EMBL; AK077116; BAC36620.1; -; mRNA.
DR   EMBL; BC021631; AAH21631.1; -; mRNA.
DR   CCDS; CCDS27686.1; -.
DR   RefSeq; NP_032695.3; NM_008669.4.
DR   SMR; Q9QWR8; -.
DR   BioGRID; 201683; 1.
DR   IntAct; Q9QWR8; 2.
DR   MINT; Q9QWR8; -.
DR   STRING; 10090.ENSMUSP00000023088; -.
DR   CAZy; GH27; Glycoside Hydrolase Family 27.
DR   GlyConnect; 2123; 1 N-Linked glycan (1 site).
DR   GlyGen; Q9QWR8; 3 sites.
DR   PhosphoSitePlus; Q9QWR8; -.
DR   SwissPalm; Q9QWR8; -.
DR   EPD; Q9QWR8; -.
DR   jPOST; Q9QWR8; -.
DR   MaxQB; Q9QWR8; -.
DR   PaxDb; Q9QWR8; -.
DR   PRIDE; Q9QWR8; -.
DR   ProteomicsDB; 252760; -.
DR   Antibodypedia; 275; 173 antibodies.
DR   Ensembl; ENSMUST00000023088; ENSMUSP00000023088; ENSMUSG00000022453.
DR   GeneID; 17939; -.
DR   KEGG; mmu:17939; -.
DR   UCSC; uc007wyw.2; mouse.
DR   CTD; 4668; -.
DR   MGI; MGI:1261422; Naga.
DR   eggNOG; KOG2366; Eukaryota.
DR   GeneTree; ENSGT00390000008751; -.
DR   HOGENOM; CLU_013093_0_0_1; -.
DR   InParanoid; Q9QWR8; -.
DR   OMA; YLYPIKN; -.
DR   OrthoDB; 964130at2759; -.
DR   PhylomeDB; Q9QWR8; -.
DR   TreeFam; TF312909; -.
DR   BRENDA; 3.2.1.49; 3474.
DR   BioGRID-ORCS; 17939; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Naga; mouse.
DR   PRO; PR:Q9QWR8; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q9QWR8; protein.
DR   Bgee; ENSMUSG00000022453; Expressed in ileum and 279 other tissues.
DR   ExpressionAtlas; Q9QWR8; baseline and differential.
DR   Genevisible; Q9QWR8; MM.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0004557; F:alpha-galactosidase activity; IBA:GO_Central.
DR   GO; GO:0008456; F:alpha-N-acetylgalactosaminidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
DR   GO; GO:0016052; P:carbohydrate catabolic process; ISS:UniProtKB.
DR   GO; GO:0019377; P:glycolipid catabolic process; ISS:UniProtKB.
DR   GO; GO:0016139; P:glycoside catabolic process; IBA:GO_Central.
DR   GO; GO:0046477; P:glycosylceramide catabolic process; IBA:GO_Central.
DR   GO; GO:0009311; P:oligosaccharide metabolic process; IBA:GO_Central.
DR   CDD; cd14792; GH27; 1.
DR   Gene3D; 2.60.40.1180; -; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR002241; Glyco_hydro_27.
DR   InterPro; IPR000111; Glyco_hydro_27/36_CS.
DR   InterPro; IPR013780; Glyco_hydro_b.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR035373; Melibiase/NAGA_C.
DR   PANTHER; PTHR11452; PTHR11452; 1.
DR   Pfam; PF16499; Melibiase_2; 1.
DR   Pfam; PF17450; Melibiase_2_C; 1.
DR   PRINTS; PR00740; GLHYDRLASE27.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00512; ALPHA_GALACTOSIDASE; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Glycosidase; Hydrolase; Lysosome;
KW   Phosphoprotein; Reference proteome; Signal.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000250"
FT   CHAIN           18..415
FT                   /note="Alpha-N-acetylgalactosaminidase"
FT                   /id="PRO_0000001019"
FT   REGION          78..79
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        156
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        217
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   BINDING         154
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         188
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         213
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         217
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17050"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17050"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        201
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        385
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        38..80
FT                   /evidence="ECO:0000250"
FT   DISULFID        42..49
FT                   /evidence="ECO:0000250"
FT   DISULFID        127..158
FT                   /evidence="ECO:0000250"
FT   DISULFID        187..209
FT                   /evidence="ECO:0000250"
FT   CONFLICT        52..53
FT                   /note="ER -> DG (in Ref. 2; CAA11703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        239
FT                   /note="L -> P (in Ref. 5; AAH21631)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   415 AA;  47235 MW;  8BBA9BE03E1350C8 CRC64;
     MLQKTVLLLA LVAQVLMLEN GLLRTPPMGW LAWERFRCNI DCVEDPKNCI SERLFMEMAD
     RLAQDGWRDL GYVYLNIDDC WIGGRDASGR LIPDPKRFPH GIAFLADYAH SLGLKLGIYE
     DMGKMTCMGY PGTTLDKVEL DAETFAEWKV DMLKLDGCFS SSRERAEGYP KMAAALNATG
     RPIAFSCSWP AYEGGLPPKV NYTEVSRVCN LWRNYKDIQD SWKSVLSILD WFVRHQDVLQ
     PVAGPGHWND PDMLLIGNFG LSFDESRAQM ALWTVLAAPL LMSTDLRTIS PQNMDILQNP
     LMIKINQDPL GIQGRRILKS KSHIEVFKRY LSNQASALVF FSRRTDMPFR FHCSLLELNY
     PKGRVYEGQN VFTGDIFSGL QTEVNFTVII NPSGVVMWYL YPIKDLGIST MMSHW
//
